Safety and Efficacy of Bimatoprost for Eyelash Growth in Postchemotherapy Subjects

about

Bimatoprost in Dermatology.

P2860

Q55016498-EB31F4AC-0607-44C4-91C5-61B3DF80617E

P2860

Safety and Efficacy of Bimatoprost for Eyelash Growth in Postchemotherapy Subjects

Item

http://www.wikidata.org/entity/Q35686630

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Safety and Efficacy of Bimatoprost for Eyelash Growth in Postchemotherapy Subjects

@ast

Safety and Efficacy of Bimatoprost for Eyelash Growth in Postchemotherapy Subjects

@en

type

Item

label

Safety and Efficacy of Bimatoprost for Eyelash Growth in Postchemotherapy Subjects

@ast

Safety and Efficacy of Bimatoprost for Eyelash Growth in Postchemotherapy Subjects

@en

prefLabel

Safety and Efficacy of Bimatoprost for Eyelash Growth in Postchemotherapy Subjects

@ast

Safety and Efficacy of Bimatoprost for Eyelash Growth in Postchemotherapy Subjects

@en

P1476

Safety and Efficacy of Bimatoprost for Eyelash Growth in Postchemotherapy Subjects

@en

P2093

David Wirta

http://www.w3.org/2001/XMLSchema#string

Emily Weng

http://www.w3.org/2001/XMLSchema#string

Gurpreet Ahluwalia

http://www.w3.org/2001/XMLSchema#string

Leslie Baumann

http://www.w3.org/2001/XMLSchema#string

Selena Daniels

http://www.w3.org/2001/XMLSchema#string

Suzanne Bruce

http://www.w3.org/2001/XMLSchema#string

P2860

Bimatoprost in the treatment of eyelash hypotrichosis

Special considerations in eye cosmetics.

Enhanced eyelashes: prescription and over-the-counter options.

Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review.

Management of hypotrichosis of the eyelashes: Focus on bimatoprost

Prostamides (prostaglandin-ethanolamides) and their pharmacology.

Ocular complications of cancer therapy: a primer for the ophthalmologist treating cancer patients.

Long-term safety evaluation of bimatoprost ophthalmic solution 0.03%: a pooled analysis of six double-masked, randomized, active-controlled clinical trials.

A randomised, double masked, multicentre clinical trial comparing bimatoprost and timolol for the treatment of glaucoma and ocular hypertension.

Normal intraocular pressure in man.

P304

11-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26060513

http://www.w3.org/2001/XMLSchema#string

P932

4456802

http://www.w3.org/2001/XMLSchema#string

Safety and Efficacy of Bimatoprost for Eyelash Growth in Postchemotherapy Subjects

about

P2860

P2860

Safety and Efficacy of Bimatoprost for Eyelash Growth in Postchemotherapy Subjects

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932